A detailed history of Stifel Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Stifel Financial Corp holds 744,128 shares of LLY stock, worth $592 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
744,128
Previous 730,203 1.91%
Holding current value
$592 Million
Previous $661 Million 0.28%
% of portfolio
0.71%
Previous 0.76%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $10.8 Million - $13.4 Million
13,925 Added 1.91%
744,128 $659 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $1.61 Million - $2.02 Million
2,218 Added 0.3%
730,203 $661 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $6.91 Million - $9.25 Million
11,669 Added 1.63%
727,985 $566 Million
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $8.32 Million - $9.81 Million
15,837 Added 2.26%
716,316 $418 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $6.81 Million - $9.38 Million
-15,656 Reduced 2.19%
700,479 $376 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $18.4 Million - $24.6 Million
-52,411 Reduced 6.82%
716,135 $336 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $3.86 Million - $4.53 Million
-12,419 Reduced 1.59%
768,546 $264 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $9.34 Million - $10.9 Million
29,057 Added 3.86%
780,965 $286 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $4.77 Million - $5.43 Million
16,072 Added 2.18%
751,908 $243 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $10.2 Million - $11.9 Million
36,438 Added 5.21%
735,836 $239 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $16 Million - $19.8 Million
68,046 Added 10.78%
699,398 $200 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $37.8 Million - $46.9 Million
168,123 Added 36.29%
631,352 $174 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $2.41 Million - $2.96 Million
-10,862 Reduced 2.29%
463,229 $107 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $6.85 Million - $8.86 Million
37,957 Added 8.7%
474,091 $109 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $5.17 Million - $6.69 Million
31,433 Added 7.77%
436,134 $81.5 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $3.11 Million - $4.11 Million
23,837 Added 6.26%
404,701 $68.3 Million
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $4.92 Million - $5.69 Million
33,626 Added 9.68%
380,864 $56.4 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $409,805 - $493,196
-3,004 Reduced 0.86%
347,238 $57 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $609,178 - $753,989
-5,117 Reduced 1.44%
350,242 $48.6 Million
Q4 2019

Feb 13, 2020

BUY
$106.92 - $132.43 $3.19 Million - $3.95 Million
29,864 Added 9.17%
355,359 $46.7 Million
Q3 2019

Nov 19, 2019

BUY
$106.79 - $116.16 $14,309 - $15,565
134 Added 0.04%
325,495 $36.4 Million
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $4.38 Million - $4.76 Million
-41,017 Reduced 11.2%
325,361 $36.4 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $9.09 Million - $10.6 Million
82,005 Added 28.84%
366,378 $40.6 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $8.68 Million - $10.2 Million
-77,988 Reduced 21.52%
284,373 $36.9 Million
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $3.76 Million - $4.21 Million
35,500 Added 10.86%
362,361 $42 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $6.21 Million - $7.76 Million
-72,290 Reduced 18.11%
326,861 $35.1 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $1 Million - $1.15 Million
-13,249 Reduced 3.21%
399,151 $34.2 Million
Q1 2018

May 11, 2018

SELL
$74.21 - $87.6 $15 Million - $17.7 Million
-201,823 Reduced 32.86%
412,400 $31.9 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $1.84 Million - $1.97 Million
22,428 Added 3.79%
614,223 $51.8 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $45.6 Million - $50.6 Million
591,795
591,795 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.